LONDON: The UK’s thrifty health authority has cleared its most expensive medicine ever – a US$700,000 GlaxoSmithKline Plc treatment for an illness known as “bubble-boy disease.”
But the overall cost to the country’s medical system won’t be as eye-popping as the price suggests.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!